Evidence map›Paper›PMID 26424886›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Dickkopf 3 Promotes the Differentiation of a Rostrolateral Midbrain Dopaminergic Neuronal Subset In Vivo and from Pluripotent Stem Cells In Vitro in the Mouse.

Yoshiyasu Fukusumi, Florian Meier, Sebastian Götz, Friederike Matheus, Martin Irmler, Ruth Beckervordersandforth, Theresa Faus-Kessler, Eleonora Minina, Benedict Rauser, Jingzhong Zhang and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 6 countries.

Yoshiyasu FukusumiInstitutes of Developmental Genetics and.
Florian MeierInstitutes of Developmental Genetics and.ORCID http://orcid.org/0000-0003-4451-5025
Sebastian GötzInstitutes of Developmental Genetics and.
Friederike MatheusInstitutes of Developmental Genetics and.ORCID http://orcid.org/0000-0002-5947-3203
Martin IrmlerExperimental Genetics, Helmholtz Center Munich, German Research Center for Environmental Health, D-85764 Neuherberg, Germany.
Ruth BeckervordersandforthEmil Fischer Centre, Institute of Biochemistry, Friedrich Alexander University Erlangen-Nuremberg, D-91054 Erlangen, Germany.
Theresa Faus-KesslerInstitutes of Developmental Genetics and.
Eleonora MininaInstitutes of Developmental Genetics and.
Benedict RauserInstitutes of Developmental Genetics and.ORCID http://orcid.org/0000-0003-4003-4208
Jingzhong ZhangInstitutes of Developmental Genetics and.
Ernest ArenasLaboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics and.
Elisabet AnderssonDepartment of Cell and Molecular Biology, Karolinska Institute, S-17177 Stockholm, Sweden.ORCID http://orcid.org/0000-0003-3095-465X
Christof NiehrsDivision of Molecular Embryology, German Cancer Research Center-Center for Molecular Biology at Heidelberg University Alliance, German Cancer Research Center, D-69120 Heidelberg, Germany, Institute of Molecular Biology, D-55128 Mainz, Germany.
Johannes BeckersExperimental Genetics, Helmholtz Center Munich, German Research Center for Environmental Health, D-85764 Neuherberg, Germany, Technical University Munich, Chair of Experimental Genetics, D-85350 Freising-Weihenstephan, Germany.
Antonio SimeoneInstitute of Genetics and Biophysics "A. Buzzati-Traverso," I-80131 Naples, Italy, Institute for Inpatient Treatment and Scientific Studies Neuromed, I-86077 Pozzilli, Isernia, Italy.
Wolfgang WurstInstitutes of Developmental Genetics and Technical University Munich, Chair of Developmental Genetics/Helmholtz Center Munich, D-85764 Neuherberg, Germany, German Center for Neurodegenerative Diseases, D-80336 Munich, Germany, and Munich Cluster for Systems Neurology, Adolf Butenandt Institute, Ludwig Maximilians University Munich, D-80336 Munich, Germany wurst@helmholtz-muenchen.de nilima.prakash@hshl.de.
Nilima PrakashInstitutes of Developmental Genetics and Technical University Munich, Chair of Developmental Genetics/Helmholtz Center Munich, D-85764 Neuherberg, Germany, wurst@helmholtz-muenchen.de nilima.prakash@hshl.de.ORCID http://orcid.org/0000-0002-0568-6262
Institutes of Science and Development · CNHelmholtz Zentrum München · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEGerman Cancer Research Center · DEGerman Center for Neurodegenerative Diseases · DEInstitute of Molecular Biology and Biophysics · RUIstituto Neurologico Mediterraneo · ITKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wingless-related MMTV integration site 1 (WNT1)/β-catenin signaling plays a crucial role in the generation of mesodiencephalic dopaminergic (mdDA) neurons, including the substantia nigra pars compacta (SNc) subpopulation that preferentially degenerates in Parkinson's disease (PD). However, the precise functions of WNT1/β-catenin signaling in this context remain unknown. Stem cell-based regenerative (transplantation) therapies for PD have not been implemented widely in the clinical context, among other reasons because of the heterogeneity and incomplete differentiation of the transplanted cells. This might result in tumor formation and poor integration of the transplanted cells into the dopaminergic circuitry of the brain. Dickkopf 3 (DKK3) is a secreted glycoprotein implicated in the modulation of WNT/β-catenin signaling. Using mutant mice, primary ventral midbrain cells, and pluripotent stem cells, we show that DKK3 is necessary and sufficient for the correct differentiation of a rostrolateral mdDA neuron subset. Dkk3 transcription in the murine ventral midbrain coincides with the onset of mdDA neurogenesis and is required for the activation and/or maintenance of LMX1A (LIM homeobox transcription factor 1α) and PITX3 (paired-like homeodomain transcription factor 3) expression in the corresponding mdDA precursor subset, without affecting the proliferation or specification of their progenitors. Notably, the treatment of differentiating pluripotent stem cells with recombinant DKK3 and WNT1 proteins also increases the proportion of mdDA neurons with molecular SNc DA cell characteristics in these cultures. The specific effects of DKK3 on the differentiation of rostrolateral mdDA neurons in the murine ventral midbrain, together with its known prosurvival and anti-tumorigenic properties, make it a good candidate for the improvement of regenerative and neuroprotective strategies in the treatment of PD. Significance statement: We show here that Dickkopf 3 (DKK3), a secreted modulator of WNT (Wingless-related MMTV integration site)/β-catenin signaling, is both necessary and sufficient for the proper differentiation and survival of a rostrolateral (parabrachial pigmented nucleus and dorsomedial substantia nigra pars compacta) mesodiencephalic dopaminergic neuron subset, using Dkk3 mutant mice and murine primary ventral midbrain and pluripotent stem cells. The progressive loss of these dopamine-producing mesodiencephalic neurons is a hallmark of human Parkinson's disease, which can up to now not be halted by clinical treatments of this disease. Thus, the soluble DKK3 protein might be a promising new agent for the improvement of current protocols for the directed differentiation of pluripotent and multipotent stem cells into mesodiencephalic dopaminergic neurons and for the promotion of their survival in situ.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell CountCell DifferentiationCells, CulturedCell SurvivalDeoxyuridineIntercellular Signaling Peptides and ProteinsMesencephalonMiceMice, Inbred C57BLMice, KnockoutNeural Stem CellsPluripotent Stem CellsTranscriptomeWnt1 Protein5-ethynyl-2'-deoxyuridineAdaptor Proteins, Signal TransducingDeoxyuridineDkk3 protein, mouseIntercellular Signaling Peptides and ProteinsWnt1 ProteinWnt1 protein, mousedifferentiationDKK3mousestem cellsubstantia nigra dopamine neuronWNT1

Identifiers

PMID26424886
PMCPMC6605475
OpenAlexW1629779103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.